department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Byetta · pharmadog

pharmadog
drugs
Byetta

drug

patient view →

exenatide

Phase 1updated 2mo ago

by $ORMP ORAMED PHARMACEUTICALS INC.

Phase 1

community read0 votes

indications

indications

Type 2 Diabetes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Byetta

generic

exenatide

indication

Type 2 Diabetes

phase

phase_1

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 56m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Trials studying exenatide

—A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugsrecruitingn=24,000
phase1Assessment of Safety, Tolerability and Drug Levels of Exenatide Implantcompletedn=24
phase4Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetescompletedn=10
phase4Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DMcompletedn=318
phase4GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetesterminatedn=15
N/AAn Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetescompletedn=70
phase4FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)completedn=102
phase4Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMcompletedn=90

more trials →